Ivis C Mendoza

Learn More
PURPOSE Racotumomab-alum is an anti-idiotype vaccine targeting the NeuGcGM3 tumor-associated ganglioside. This clinical trial was conducted to provide a preliminary estimate of efficacy and safety of racotumomab as switch maintenance for patients with advanced non-small cell lung cancer (NSCLC). EXPERIMENTAL DESIGN Patients with stage IIIb/IV NSCLC who(More)
INTRODUCTION Recombinant human erythropoietin (RHuEPO) is an erythropoiesis stimulating agent (ESA) used to treat anemia in patients with total or relative erythropoietin deficit. In cancer patients, it is administered to optimize hemoglobin (Hb) levels, correct anemia and reduce the need for transfusions. Cuba produces a RHuEPO, registered in 1998 as(More)
This retrospective study characterized the recurring ventricular arrhythmias with an electrogram-storing defibrillator in survivors of sudden cardiac death who had no inducible sustained ventricular arrhythmias at baseline electrophysiologic testing (EPS). The study group was composed of 24 selected patients with documented ventricular fibrillation (VF)(More)
Maurenis Hernandez, Ramon A. Ortiz, Elia Neninger, Rosa M. Amador, Mireisy Cala, Kirenia Camacho, Eva Salomon, Pedro P. Guerra, Ivis Mendoza, Carlos Sanchez, Carmen Viada, Matilde Gonzalez, Lourdes T. Torres, Vivian Fonseca, Ivon Garcia, Loisel Bello, Maribel Alonso, Maria C. Rodriguez, Aivin Cruz, Rolando Valdes, Geidy Lorenzo, Meylan Cepeda, Yaimarelis(More)
The otologist frequently sees patients with progressive sensorineural hearing loss, subjective aural tinnitus and vertigo with no apparent cause. Elevated blood lipids may be a cause of inner ear malfunction on a biochemical basis. To establish the true incidence of this condition, all new patients (4,251) seen during an eight-year period were evaluated; of(More)
  • 1